Drug
Bevacizumab
Bevacizumab: highest development phase Phase 2, developed by Chugai, Roche. 4 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Chugai, Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| bevacizumab (Avastin) NCT00605722 | Phase 2 | Liver Cancer |
| Bevacizumab NCT02079519 | Phase 2 | Multiple Myeloma |
| Bevacizumab NCT00483834 | Phase 2 | Colorectal Cancer |
| Bevacizumab NCT04097444 | Phase 2 | Metastatic Colorectal Cancer |
Latest
No recent events.
Follow Bevacizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.